Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether desmoteplase is effective and safe in the
treatment of patients with acute ischaemic stroke when given within 3-9 hours from onset of
stroke symptoms.